COSCIENS Biopharma Inc. (TSX:CSCI)
2.470
-0.010 (-0.40%)
May 21, 2026, 3:59 PM EST
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of CAD 7.9 million as of May 21, 2026. Its market cap has decreased by -38.93% in one year.
Market Cap
7.90M
Enterprise Value
3.73M
Revenue
11.17M
Ranking
n/a
PE Ratio
1.40
Stock Price
2.47
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 14.82B to 7.90M, a decrease of -99.95%. That is a compound annual growth rate of -22.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 7.90M | -12.65% |
| Dec 31, 2025 | 9.04M | 30.63% |
| Dec 31, 2024 | 6.92M | -44.54% |
| Dec 29, 2023 | 12.48M | -40.23% |
| Dec 30, 2022 | 20.88M | -62.20% |
| Dec 31, 2021 | 55.24M | 63.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemostemix | 11.87M |
| Glow Lifetech | 10.58M |
| Marvel Biosciences | 10.08M |
| Innovotech | 7.35M |
| Quest PharmaTech | 6.77M |
| MindBio Therapeutics | 6.55M |
| Kane Biotech | 6.36M |
| Aptose Biosciences | 5.95M |